Why is Lululemon stock recovering today?
Why is Lululemon stock recovering today?
Lululemon stock gained 1.7% in afternoon trading to reach $102.30, staging a tentative relief bounce after last week’s devastating selloff that saw shares plunge roughly 18% in the wake of deeply disappointing Q2 fiscal 2026 results.
The company reported a 4% revenue decline to $2.416 billion — missing consensus estimates — alongside a 9% drop in comparable sales, a 20% slump in its core leggings category, and a severe cut to full-year guidance, sending the stock crashing toward its 52-week low of $97.99.
With the earnings shock and the subsequent wave of analyst price target reductions now fully absorbed by the market, some investors appear to be stepping in at what they view as a historically compressed valuation.
Barclays maintained its Equalweight rating but slashed its price target to $95 from $113, while UBS cut its target to $106 from $120 and maintained a Neutral stance, noting that product assortment is not resonating with consumers and that traffic remains weak. Morgan Stanley cut its target to $83. Despite the cautious tone, InvestingPro’s model fair value sits at $163.24 — implying a significant discount to intrinsic value — which is drawing some speculative interest.
The broader market context is working against LULU today, with the S&P 500 down 0.4%, the Dow Jones down 1.1%, and the Nasdaq off 0.2%, making the stock’s positive move entirely company-specific. The imminent arrival of incoming CEO Heidi O’Neill — expected to officially take the helm this week — is providing a thin layer of "new chapter" optimism, as investors hope a fresh leadership perspective could begin to address the structural challenges around North American demand, product relevance, and China sentiment headwinds.
Taken together, today’s move reflects a short-term technical stabilization rather than a fundamental re-rating: the stock is bouncing from near multi-year lows after an extreme selloff, even as the underlying business continues to face declining comparable sales, elevated markdowns, and a guidance trajectory that points to further revenue contraction in the quarters ahead.